Community Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Buy
532
+56
+12% +$10.5K 0.01% 246
2026
Q1
$93.9K Hold
476
– – 0.01% 242
2025
Q4
$87.5K Hold
476
– – 0.01% 254
2025
Q3
$73K Buy
+476
New +$72K 0.01% 260
2022
Q4
– Sell
-151
Closed -$17K – 495
2022
Q3
$17K Buy
+151
New +$19.2K ﹤0.01% 348
2019
Q4
– Sell
-119
Closed -$11K – 422
2019
Q3
$11K Hold
119
– – ﹤0.01% 351
2019
Q2
$10K Hold
119
– – ﹤0.01% 363
2019
Q1
$10K Hold
119
– – ﹤0.01% 374
2018
Q4
$9K Hold
119
– – ﹤0.01% 369
2018
Q3
$9K Hold
119
– – ﹤0.01% 414
2018
Q2
$8K Hold
119
– – ﹤0.01% 423
2018
Q1
$8K Hold
119
– – ﹤0.01% 442
2017
Q4
$8K Buy
+119
New +$8.03K ﹤0.01% 543

Other funds holding AZN

Community Bank's AZN Position: Q2 2026 in Review

Community Bank increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $10.5K and bringing the position to 532 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #246.

Community Bank first reported a position in AZN in Q4 2017 and has held it in 13 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Community Bank held 532 shares of AstraZeneca worth $101K as of Q2 2026.
  • Community Bank bought 56 AstraZeneca shares in Q2 2026, an estimated $10.5K.
  • AstraZeneca made up 0.01% of Community Bank's portfolio in Q2 2026, its #246 holding.
  • Community Bank first reported a position in AstraZeneca in Q4 2017 and has held it in 13 quarters since.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Community Bank's 13F filing for Q2 2026, filed 13 Aug 2026.